ICMR Initiates Public Consultation on Ethical Framework for Non-Regulatory Clinical Trials

The Indian Council of Medical Research (ICMR) has taken a significant step toward strengthening the ethical architecture of scientific research in India by inviting public consultation on a draft framework for 'non-regulatory' clinical trials. While regulatory trials—those conducted for drug approval or medical device licensing—are governed by stringent statutory frameworks like the New Drugs and Clinical Trials Rules, 2019, non-regulatory research often operates in a grey area. This includes academic research, observational studies, and public health surveys that, while not aimed at commercial product approval, still involve human participants and carry inherent risks. The move is a proactive effort to ensure that scientific curiosity does not override the fundamental rights of participants. Ethical oversight in such trials is crucial to prevent exploitation, ensure informed consent, and maintain the integrity of data. By seeking public input, the ICMR aims to democratize the policy-making process, ensuring that the guidelines are not only scientifically robust but also socially acceptable and practically implementable. This initiative reflects the evolving nature of bioethics in India, where the focus is shifting from mere compliance to a culture of 'ethical by design' research.